Qing-Qing Dai

Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors.

Shaomeng Wang, Zhe-Sheng Chen, Guo‐Bo Li, 2021, Journal of medicinal chemistry.

MeDBA: the Metalloenzyme Data Bank and Analysis platform

C. Schofield, Qing-Qing Dai, Guo-Bo Li, 2022, Nucleic Acids Res..

Targeting Metalloenzymes by Boron-Containing Metal-Binding Pharmacophores.

You‐Cai Xiao, Qing-Qing Dai, Guo-Bo Li, 2021, Journal of medicinal chemistry.

Recent advances in β-lactamase inhibitor chemotypes and inhibition modes.

X. Chen, Lingling Yang, Rong Li, 2022, European journal of medicinal chemistry.

MeLAD: an integrated resource for metalloenzyme-ligand associations

Chen Fu, Cheng Huang, Gen Li, 2019, Bioinform..

Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates.

Lingling Yang, Zhouyu Wang, Hua-Li Wang, 2021, European journal of medicinal chemistry.

Deep learning in target prediction and drug repositioning: recent advances and challenges.

Qing-Qing Dai, Guo-Bo Li, Junlin Yu, 2021, Drug discovery today.

MeCOM: A Method for Comparing Three-Dimensional Metalloenzyme Active Sites

Qing-Qing Dai, Guo-Bo Li, Gen Li, 2022, J. Chem. Inf. Model..